Pfizer Could Have Pandemic Trial Results in Weeks

Pfizer (PFE) just announced it could have results from its late-state coronavirus study as soon as October 2020. “We expect by the end of October, we should have enough … to say whether the product works or not,” said CEO Albert Bourla, as quoted by CNBC.

“The pharmaceutical company has already enrolled 23,000 volunteers in the phase three trial that began in late July, Bourla said during a Q&A with the International Federation of Pharmaceutical Manufacturers & Associations, a trade group. It hopes to enroll at least 30,000 participants.”